Fennec Pharmaceuticals Ratios (2010-2025) | FENC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)									94.34%	95.55%	94.92%	92.96%	97.83%	35.67%	80.54%	50.23%	95.74%	89.98%	58.19%	55.68%
EBT Margin (Quarter)									-355.34%	-161.68%	-27.18%	-26.89%	50.86%	-75.92%	-81.89%	-18.94%	-13.30%	-32.69%	-5.00%	15.48%
EBIT Margin (Quarter)									-314.25%	-140.33%	-15.61%	-18.67%	54.16%	-69.39%	-74.59%	-11.79%	-9.23%	-28.31%	-1.52%	16.06%
EBITDA Margin (Quarter)									-314.25%	-140.33%	-15.61%	-18.67%	54.16%	-69.39%	-74.59%	-11.79%	-9.23%	-28.31%	-1.52%	16.06%
Operating Margin (Quarter)									-314.25%	-140.33%	-15.61%	-18.67%	54.16%	-69.39%	-74.59%	-11.79%	-9.23%	-28.31%	-1.52%	16.06%
Net Margin (Quarter)									-355.34%	-161.68%	-27.18%	-26.89%	50.86%	-75.92%	-81.89%	-18.94%	-13.30%	-32.69%	-5.00%	15.48%
FCF Margin (Quarter)									-332.56%	-118.68%	-42.36%	-49.92%	147.01%	-115.49%	-31.63%	-18.60%	-49.34%	-38.19%	11.98%	-43.28%
Efficiency
Assets Average (Quarter)	29.62M	27.97M	27.06M	24.21M	20.78M	17.36M	22.99M	28.68M	24.38M	20.63M	19.71M	23.42M	48.03M	66.18M	61.04M	51.93M	45.67M	45.64M	47.07M	59.91M
Equity Average (Quarter)	27.00M	23.61M	20.65M	17.39M	14.15M	10.53M	5.67M	0.12M	-4.95M	-8.53M	-10.13M	-11.08M	-4.30M	0.83M	-3.26M	-5.52M	-5.88M	-6.67M	-5.98M	15.49M
Invested Capital (Quarter)	24.93M	27.28M	24.01M	20.77M	13.02M	9.54M	2.80M	22.43M	17.66M	15.27M	14.47M	18.38M	33.01M	28.64M	24.83M	12.33M	12.33M	10.74M	13.71M	35.47M
Asset Utilization Ratio (Quarter)	0.01								0.08	0.25	0.58	0.91	0.94	0.74	0.81	0.92	0.68	0.73	0.82	0.75
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-0.00M	-435.56	-75.87		-61.14	-87.88	-66.38	-6.71	-6.60	-5.66	-1.19	-1.99	13.29	-4.83	-5.08	-0.97	-1.36	-4.60	-0.32	7.19
Debt to Equity (Quarter)				0.32	0.40	0.59	8.92
Debt Ratio (Quarter)				0.22	0.26	0.32	0.82
Equity Ratio (Quarter)	0.90	0.79	0.73	0.70	0.65	0.55	0.09	-0.10	-0.34	-0.50	-0.53	-0.43	0.04	-0.02	-0.09	-0.13	-0.13	-0.17	-0.09	0.50
Times Interest Earned (Quarter)	-0.00M	-435.56	-75.87		-61.14	-87.88	-66.38	-6.71	-6.60	-5.66	-1.19	-1.99	13.29	-4.83	-5.08	-0.97	-1.36	-4.60	-0.32	7.19
Valuation
Enterprise Value (Quarter)	-26.75M	-27.29M	-24.34M	-21.10M	-18.26M	-14.91M	-29.75M	-23.77M	-13.27M	-14.96M	-12.40M	-13.27M	-51.18M	-43.05M	-40.32M	-26.63M	-22.68M	-18.70M	-21.95M	-36.79M
Return Ratios
Return on Sales (Quarter)	-0.95%								-0.04%	-0.02%	0.00%	0.00%	0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-70.98%	-66.54%	-65.32%		-88.83%	-116.24%	-102.80%	-93.85%	-119.42%	-142.25%	-108.19%	-80.48%	16.34%	10.04%	3.14%	5.70%	-32.12%	-25.99%	-12.52%	-3.07%
Return on Assets (Quarter)	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.03%	-2.02%	0.05%	0.03%	0.02%	0.01%	-0.01%	0.04%	0.00%	0.00%	0.02%	0.02%	0.01%	0.00%

Research Tools

Fennec Pharmaceuticals Ratios (2010-2025) | FENC

Create an account

Sign In

Reset Password